In both systemic onset juvenile idiopathic arthritis patients and in Sjogren’s syndrome, TNF inhibition led to an increased IFN signature supporting the hypothesis that TNF- and IFN-driven pathologies may lie at opposite poles of the autoimmune disease spectrum [46], [47]. The gene discussed is IFNA1; the disease is juvenile idiopathic arthritis.